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cognitive resilience to Alzheimer’s disease in genetically
diverse mice
Sarah E. Heuer,1,2 Sarah M. Neuner,1,3 Niran Hadad,1 Kristen M.S. O’Connell,1
Robert W. Williams,3 Vivek M. Philip,1 Chris Gaiteri,4 and Catherine C. Kaczorowski1,2
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The Jackson Laboratory, Bar Harbor, Maine 04609, USA; 2Tufts University School of Graduate Biomedical Sciences, Boston,
Massachusetts 02111, USA; 3University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA; 4Rush Alzheimer’s
Disease Center, Rush University Medical Center, Chicago, Illinois 60612, USA
Individual differences in cognitive decline during normal aging and Alzheimer’s disease (AD) are common, but the molecular mechanisms underlying these distinct outcomes are not fully understood. We utilized a combination of genetic, molecular, and behavioral data from a mouse population designed to model human variation in cognitive outcomes to search
for the molecular mechanisms behind this population-wide variation. Specifically, we used a systems genetics approach to
relate gene expression to cognitive outcomes during AD and normal aging. Statistical causal-inference Bayesian modeling
was used to model systematic genetic perturbations matched with cognitive data that identified astrocyte and microglia molecular networks as drivers of cognitive resilience to AD. Using genetic mapping, we identified Fgf2 as a potential regulator
of the astrocyte network associated with individual differences in short-term memory. We also identified several immune
genes as regulators of a microglia network associated with individual differences in long-term memory, which was partly
mediated by amyloid burden. Finally, significant overlap between mouse and two different human coexpression networks
provided strong evidence of translational relevance for the genetically diverse AD-BXD panel as a model of late-onset AD.
Together, this work identified two candidate molecular pathways enriched for microglia and astrocyte genes that serve as
causal AD cognitive biomarkers, and provided a greater understanding of processes that modulate individual and population-wide differences in cognitive outcomes during AD.
[Supplemental material is available for this article.]
Alzheimer’s disease (AD) dementia is a common neurodegenerative disorder deﬁned by extracellular amyloid plaques and intracellular neuroﬁbrillary tangles, and characterized by progressive
memory decline (Selkoe 1991). Many of the tested therapies for
AD have focused on targeting and clearing pathological
beta-amyloid (Aβ), which has been extensively researched as an
initiating factor that leads to neurodegeneration and cognitive
impairment (Hardy and Selkoe 2002; Selkoe and Hardy 2016). To
date, therapeutics to delay or reverse the progression of
AD-related cognitive decline have been disappointing, despite signiﬁcantly removing Aβ burden (Gao et al. 2016; Elmaleh et al.
2019). These drug failures, and investigations into the origin of
AD more broadly, are both impacted by the divergence between
the clinical (cognitive decline) and pathological (amyloidosis and
hyperphosphorylated tau) presentation of the disease, with some
cognitively intact elderly individuals exhibiting signiﬁcant amyloidosis consistent with new diagnostic criteria for AD (Morris
et al. 1996; Budson and Solomon 2012; Negash et al. 2013). Even
individuals with well-deﬁned familial AD (FAD) mutations in amyloid precursor protein (APP) or presenilin 1 (PSEN1) genes can
maintain cognitive function well beyond their sixth decade, despite robust amyloid and tau pathological burden, identifying individuals that are resilient to pathology-induced cognitive decline
(Crystal et al. 1988; Katzman et al. 1988; Ryman et al. 2014;

Arenaza-Urquijo and Vemuri 2018). In light of this disconnect between AD pathology and cognitive symptoms, there is a critical
need to understand how genetic background can modify the impact of amyloid on variation in AD cognitive decline.
Recent advances in genomic techniques have enabled detailed investigation of cognitive decline using genome-wide transcriptional proﬁling from postmortem brains of demented and
nondemented control individuals (Miller et al. 2013; Zhang et al.
2013; Narayanan et al. 2014; De Jager et al. 2018). Although these
studies have identiﬁed some of the processes associated with cognitive decline, such as increased brain inﬂammation and neurodegenerative pathways, there is still an incomplete understanding
of the factors that directly drive cognitive outcomes in dementia
patients. One recent study used an integrative approach which
combined postmortem gene coexpression, measures of cognitive
decline, and measures of pathology to generate a Bayesian
conditional-dependency network that identiﬁed several modules
predicted to directly inﬂuence cognitive decline without pathology (Mostafavi et al. 2018). This was a key development in understanding the complex etiology of AD-related cognitive decline in
that rather than identifying correlational relations, this study
used Bayesian directed modeling that incorporated molecular networks, pathological, and cognitive measures to propose a candidate biological network that directly inﬂuenced cognitive decline
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es in cognition in an aging and AD populations, and evaluates the
without the direct inﬂuence of pathology. However, the reliance
effect of these systems on cognitive outcomes. Furthermore, addion postmortem tissues limits our ability to deﬁne early molecular
tional modeling that incorporated cortical Aβ1-42 ELISA suggests
changes that may drive onset of dementia, especially since many
an indirect relation of AD pathological burden on cognitive outof these processes start long before the onset of cognitive sympcomes in promoting differences in molecular network activity,
toms (Fox et al. 1996; Paterson et al. 2014; Hohman et al. 2017).
and highlights the utility of mouse models for discovering several
To identify novel genetic factors and molecular systems that
are responsible for resilience to cognitive symptoms of AD longitumolecular systems to monitor for resilience and manipulate them
dinally and under controlled environmental conditions, we sysin future validation studies to improve AD cognitive outcomes.
tematically examined the effect of FAD mutations on cognitive
traits in a genetically diverse panel of mice; the AD-BXDs
Results
(Neuner et al. 2019a). The AD-BXD genetically diverse mouse model of AD incorporates the commonly used 5XFAD transgene across
Defined molecular systems of the hippocampus in AD-BXD
a number of diverse, yet inbred, mouse strains from the BXD genetand Ntg-BXD mice
ic reference panel (Neuner et al. 2019a). We found that the
AD-BXDs exhibited variation in cognitive decline similar to that
In order to identify the molecular systems associated with cogniobserved in human FAD populations (Ryman et al. 2014). This vartive outcomes across the population of both AD and non-AD
iation was sensitive to genetic risk factors associated with human
mouse strains, we ﬁrst obtained RNA sequencing (RNA-seq) data
sporadic AD (Neuner et al. 2019a), suggesting this is a translationally relevant
model of late-onset AD (LOAD).
A
The goal of this study is to build on
our previous ﬁndings to further prioritize
the molecular systems which likely account for the wide range of cognitive
outcomes using a population of identical individuals with and without AD
mutations. We took a systems biology
approach combining genetic, transcriptomic, and behavioral data from a large
population of normal aging (Ntg-BXD)
B
and AD (AD-BXD) cases (Fig. 1). Speciﬁcally, we inferred gene coexpression modules from hippocampus transcriptome
data of a genetically diverse mouse population from young [6 mo old (6 mo)] and
aged [14 mo old (14 mo)] individuals.
Each of these modules represents the activity of one or more molecular systems,
and was identiﬁed in a purely data-driven
manner, blind to genotype or behavioral
D
C
outcomes. Then, we identiﬁed which
modules and molecular systems were associated with age, amyloid mutations,
and cognitive outcomes. Genetic mapping of module eigengene expression as
quantitative traits identiﬁed genetic regions that regulated each module. We
then used Bayesian conditional dependency modeling (Tasaki et al. 2015) to eliminate redundant associations and predict Figure 1. Genetically diverse mice can be leveraged to understand the relevant molecular networks
the subset of modules driving individual that underlie individual differences in cognitive outcomes. Schematic of SpeakEasy module formation
and relation to cognitive outcomes, adapted from Mostafavi et al. (2018). (A) Multiple strains of genetdifferences in cognition across the popuically diverse mice that are carriers (AD-BXD) or noncarriers (Ntg-BXDs) for the 5XFAD transgene (FAD
lation, and calculated if these relations mutations) are combined to generate a population with genetic diversity similar to what is observed in
were dependent on the presence of humans. These strains make up a genetic reference panel, allowing for the incorporation of genetic inamyloid-driving mutations, and if mod- formation into further analyses. Each mouse is brought through a cognitive phenotyping pipeline (deule–trait relations were strengthened by scribed in Neuner et al. 2019a), taking measures for working memory, short-term memory, and
the addition of cortical amyloid burden long-term memory at 6 mo or 14 mo of age, and harvest of hippocampal tissue for downstream analyses. (B) Measures of the three cognitive domains taken during the phenotyping pipeline are assessed
into our statistical model. Finally, we test- from AD-BXD and Ntg-BXD mice at 6 mo and 14 mo of age (left), while gene coexpression modules
ed if the prioritized molecular networks are separately formed from the same mice using SpeakEasy consensus clustering (middle).
from this study are translationally rele- Additionally, genetic information is obtained from each strain for downstream genetic mapping and invant by testing the overlap between tegration into the module-trait network (right). (C) Gene expression modules are related to cognitive
mouse and human dementia networks traits using Spearman correlations, and modules signiﬁcantly (adj. P < 0.05) correlated to at least one
(Bennett et al. 2012; Mostafavi et al. cognitive measure are selected for downstream analysis. These cognitively relevant modules are integrated with cognitive measures, and anchored by BXD genetics to form a module-trait Bayesian directed
2018; Wan et al. 2020). This approach network, and modules directly upstream of cognitive traits are prioritized for further characterization.
nominates robust molecular systems that (D) Cognitively relevant modules are compared with human brain modules to investigate gene–gene
consistently relate to individual differenc- conservation between mouse and human.
www.learnmem.org
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acterized based on cell-type and biological function, without having overlapping members since each module was formed using
discrete gene assignment. These included a group of modules enriched for genes expressed in neurons, as well as synaptic organization and intracellular transport GO terms, a large grouping of
astrocyte modules enriched for RNA processing, cell movement,
and chromatin remodeling GO terms, a mixed endothelial cell
and astrocyte grouping of modules enriched for metabolism GO
terms, and a microglia module group enriched for immune function GO terms (Fig. 2). The annotation of these covarying molecular systems identiﬁes the major cell-types and biological pathways
present in the hippocampus of our population, a subset of which
may change as a function of aging and/or disease processes.

from the hippocampus of AD-BXD and Ntg-BXD mice at either 6 or
14 mo of age (n = 294) (Neuner et al. 2019a,b). Biological replicates
from the strain, sex, and genotype groups were averaged together,
generating a total of 156 unique group-averaged measures.
With these data, we then performed unsupervised consensus clustering and identiﬁed 28 discrete transcriptional modules of >29
genes, ranging in membership size from 42 to 1419 transcripts
(Supplemental Table S1). We commonly refer to these modules
as gene sets, but recognize that in this context we more formally
mean sets of mRNAs with one-to-one relations to genes. We chose
the SpeakEasy consensus clustering algorithm over other clustering algorithms, such as weighted gene coexpression network analysis (WGCNA), because it is less parameter-driven and carries a
higher degree of run-to-run stability for transcriptome network
conservation (Gaiteri et al. 2015; Mostafavi et al. 2018). To gain a
basic understanding of the biological processes and cell-types enriched in each module, we performed gene ontology (GO) biological process enrichment on each module (Supplemental Table S2),
as well as cell-type enrichment using a well-established and mineable RNA-seq data set from mouse cortex (Zhang et al. 2014). The
major molecular functions and module–module relations of these
gene sets are highlighted in Figure 2. Modules that were clustered
together based on covariation in expression are also similarly char-

Prioritizing molecular systems related to cognitive
outcomes highlights immune and metabolic networks
The coexpression analysis described above deﬁned the basic molecular systems that can be robustly identiﬁed and evaluated in mouse
hippocampi. Importantly, these mRNA sets are formed without
any reference to genotype or phenotype. Therefore, we next considered how the average expression of each coexpression module
was related to sex, age, and FAD mutation carrier status

Figure 2. AD-BXD and Ntg-BXD have variable transcriptional networks across aging and Alzheimer’s individuals. SpeakEasy consensus clustering identiﬁed 31 discrete transcriptional modules from hippocampal RNA sequencing of Ntg/AD-BXD mice (n = 26 strains). Modules containing <30 genes were
excluded (n = 3 modules). Average module expression per sample was derived using average standardized gene expression of module members. Modules
were correlated to each other (Pearson) and hierarchically clustered. Cell-type enrichment was performed on the genes within each module using the
Zhang et al. (2014) data set to obtain an idea of represented cell-types for each module. Cell-type enrichments were performed using hypergeometric
tests to identify signiﬁcant relationships (adj. P < 0.05) for astrocytes, endothelial cells (EC), neurons, microglia, oligodendrocyte precursor cells (OPC),
new oligodendrocytes (New Oligo.), and myelinating oligodendrocytes (Myelin. Oligo.). GO enrichment was performed on the genes in each module,
and the GO term most signiﬁcantly enriched within a module is denoted (NS GO = no signiﬁcant GO enrichment).
www.learnmem.org
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(Supplemental Figs. S1–S3), and cognitive status (Fig. 2). To do this,
we ﬁrst generated a summary statistic for each module by calculating the average standardized expression of the gene members for
each module. Next, we compared each module summary statistic
with strain-averaged performance on cognitive tasks using
Spearman correlation analysis. These tasks spanned multiple cognitive domains and included working memory using spontaneous
alternation on the Y-maze and acquisition and recall of contextual
fear conditioning at both 6 and 14 mo of age. Spontaneous alternation relies on a rodent’s innate tendency to explore novel environments while avoiding familiar environments and assesses
hippocampal- and cortical-dependent spatial working memory.
This task was initially chosen due to the lack of need for training,
reward, or punishment, and the ability to test mice on this task longitudinally (Holcomb et al. 1998; Ohno et al. 2004; Oakley et al.
2006). Contextual fear conditioning enables the assessment of
both hippocampal-dependent short-term memory during the
acquisition phase in which mice are administered four mild
foot shocks (Chen et al. 1996; Neuner et al. 2015), as well as
hippocampal-dependent spatial orientation, recall, and long-term
memory during the testing phase in which mice are placed back
into the training chamber in the absence of foot shocks 24 h after
contextual fear conditioning training (Kim and Jung 2006; Neuner
et al. 2015).
We identiﬁed 16 modules that signiﬁcantly correlated with at
least one cognitive outcome (Fig. 3A; Spearman, adj. P < 0.05).

There were 6 modules (5 negative, 1 positive) signiﬁcantly correlated with percent successful spontaneous alternations (%SA) on the
Y-maze working memory task. The modules negatively correlated
with %SA on the Y-maze working memory task (m2, m4, m6,
m7, m8) contain genes highly expressed in microglia, and enriched for GO biological processes including cell migration, immune function, and lipid biosynthesis processes. The only
module positively correlated with %SA on Y-maze (m20) contained members that are also expressed in microglia and were enriched for noncoding RNA processing GO terms. There were 16
modules (8 negative, 8 positive) that signiﬁcantly correlated with
contextual fear acquisition (CFA) slope (see Materials and Methods). The negatively correlated modules contained genes expressed
in astrocytes and microglia and were primarily enriched for GO
terms associated with immune function (m4, m5, m6) as well as
cell migration (m1, m2, m3) and lipid biosynthesis and metabolism (m7, m8). The positively correlated modules contained genes
expressed primarily in neurons and were enriched for GO processes
associated with synaptic signaling and organization (m13, m15,
m16, m23, m28), mitochondrial transport (m18), and RNA
processing and metabolism (m14, m20). Finally, there were 6
modules (5 negative, 1 positive) signiﬁcantly correlated with contextual fear memory (CFM). The negatively correlated modules
contained genes expressed in microglia and astrocytes and were enriched for migration (m2), immune (m4, m5, m6) and lipid biosynthesis (m7) processes. The positively correlated module (m14) was
enriched for genes associated with purine
metabolism processes and contained
genes expressed in multiple cell-types inA
cluding endothelial cells, neurons, microglia, and myelinating oligodendrocytes.
One thing to note is that we identiﬁed
four modules that were signiﬁcantly correlated with all three cognitive outcomes
(m2, m4, m6, m7), suggesting perturbation of these modules would inﬂuence
all three cognitive domains, instead of
being-domain speciﬁc processes. Together, results from these analyses suggest
that increased number of transcripts assoB
C
ciated with antiviral and innate immune
pathways in microglia, as well as lipid biosynthesis pathways in astrocytes associate
with lower cognitive performance, while
synaptic signaling and purine metabolism pathways that are enriched in neuron and oligodendrocyte precursor cells
are associated with higher cognitive performance, highlighting these biological
D
networks as resilience candidates.
In addition to identifying signiﬁcant
module–trait relations, we also tested the
extent to which signiﬁcantly correlated
modules explained variance in cognitive
outcomes across the population. Initially,
we calculated heritability of each trait to
determine the amount of variance genetic background (or BXD strain) explained
for each cognitive outcome. Similar to
Figure 3. Correlation analysis reveals a select sixteen modules related to cognitive outcomes.
our previous ﬁndings (Neuner et al.
(A) Average standardized module expression was correlated to cognitive traits to identify modules
that may signiﬁcantly modify cognitive function. Modules signiﬁcantly (Spearman, adj. P < 0.05) corre2019a), the majority of the variance in
lated to measures of working, short-term, and long-term memory are highlighted above. (B–D) The procognitive outcomes could be explained
portion of variance in measures for working memory (B), short-term memory (C), and long-term
by genetic background, with 73% heritamemory (D) explained by individual module average expression. Bars are colored based on directionality
bility for %SA on Y-maze working memoof correlation to cognitive measure, with positive correlations in blue and negative correlations in red. All
ry, 70% heritability for CFA slope, and
modules are denoted by the most signiﬁcantly enriched GO term (NS GO = no signiﬁcant GO
89% heritability for CFM. Using threeenrichment).
www.learnmem.org
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way ANOVA analyses we separately calculated the amount of variance in each cognitive outcome that could be explained by binarycoded variables such as age, sex and presence of FAD mutations
(Supplemental Table S3). Age was the only variable that signiﬁcantly affected %SA on Y-maze working memory, explaining
8.2% of the variance in %SA. Additionally, age was the only variable explaining signiﬁcant variance for CFM, explaining 12.7%
of the variance in %freezing on this task. Finally, age and FAD mutation carrier status explained signiﬁcant variance for CFA slope,
with 4.6% explained by age, and 19.9% explained by FAD mutation carrier status.
Using linear regression modeling, the variance of each cognitive outcome explained by module expression was calculated and
used as a proxy for effect size of module expression on cognitive
outcomes. We focused only on module–trait relationships that
reached statistical signiﬁcance in our Spearman correlation analysis, and performed individual linear regressions for each module–
trait pair. The modules that explained the most variance for working memory (%SA) outcomes were the epithelial migration module
(m2, 5.6%), lipid biosynthesis module (m7, 5.8%) and coenzyme
metabolism module (m8, 5.7%) (Fig. 3B). Variance in CFA shortterm memory outcomes was explained more strongly and by a larger number of modules than %SA, including immune modules (m4,
24.0%; m5, 16.0%, m6, 21.3%), and the lipid biosynthesis module
(m7, 27.8%) (Fig. 3C). The modules that explained the greatest
amount of variance for CFM long-term memory outcomes included the immune: virus module (m5, 10.5%), lipid biosynthesis module (m7, 9.3%), and purine metabolism module (m14, 7.7%) (Fig.
3D). While these module-trait correlations can prioritize molecular
systems in disease, the causal nature of these relationships is unclear. Therefore, we proceeded to integrate genetic priors and conditional dependences to further assess the robustness of the top
ﬁndings from these initial results.

Figure 4. Bayesian conditional dependency modeling of cognitively relevant modules and traits deﬁnes causal module–trait relationships.
Genetics (green triangles), module expression (blue circles, denoted by
most signiﬁcantly enriched GO term), and measures for each cognitive
domain (red diamonds) were combined into a single module-trait
network using Bayesian conditional dependency modeling. The
genomic priors used in this analysis were the identiﬁed genetic regions associated with module eigengenes (PC1), and the chromosome(s) that
each region mapped to is denoted inside each triangle. The thickness of
the arrows represents the number of times a module–module or
module–trait relationship was detected.

Genetic network analysis supports a role for lipid
biosynthesis and viral immune enriched molecular
networks in cognitive resilience
As the effect of a molecular system on a phenotype may be conditional on activation of other molecular systems, we tested for such
relations in the module-trait associations we identiﬁed. In this
analysis, we simultaneously utilized module expression for the
16 cognitive relevant modules, cognitive measures, as well as information about genomic regions involved in regulating module expression. Chromosomal regions that regulate module expression
were identiﬁed using genetic mapping in which module eigengenes were used as quantitative traits. According to the central
dogma of expression genetics (Crick 1958; Williams et al. 2007),
DNA variants inﬂuence RNA expression, which then modulates
downstream behavioral phenotypes such as cognitive outcomes
(Hsu et al. 2007). As such these chromosomal regions were used
as causal anchor points in our Bayesian network analysis to attempt to identify which molecular networks (and chromosomal regions) were causally associated with cognitive outcomes. The
modules predicted to directly inﬂuence cognitive outcomes were
m7 (astrocytes, lipid biosynthesis) for Y-maze working memory
and CFA short-term memory and m5 (microglia, immune: virus)
for CFM long-term memory (Fig. 4).
The module directly upstream of Y-maze working memory
and CFA short-term memory, m7, also explained the most variance
in these cognitive measures (Fig. 3B,C). Module m7 contained 243
gene members, making it smaller in size in comparison to the three
major microglia modules with 1088 members in m4, 848 members
in m5, and 681 members in m6. This module was most signiﬁcantly enriched for GO terms related to lipid biosynthesis and for
genes that are highly expressed in astrocytes (Fig. 2). Ingenuity
www.learnmem.org

pathway analysis (IPA) identiﬁed multiple molecular systems enriched in this gene set consistent with astrocyte activity including
Interleukin-1 (IL-1) signaling, cholesterol biosynthesis and actin
cytoskeleton signaling (Table 1). Speciﬁcally, the m7 genes enriched in the IL-1 signaling pathway were Irak2 and Irak3, part of
the IRAK family of proteins that are involved in direct downstream
signaling of the IL-1 receptor, as well as Rhoa, which is important to
actin cytoskeleton signaling.
The module directly upstream of CFM long-term memory
outcomes was m5, enriched for GO biological processes associated
with viral immune response (Fig. 2). This module consisted of 848
gene members, making it one of the largest modules constructed in
this analysis. Enrichment of this module for GO biological processes and IPA canonical pathways highlighted the primary function
of this module was proinﬂammatory immune signaling.
Speciﬁcally, many of the enriched IPA canonical pathways referenced pathways involved in immune responses to virus, such as
“role of pattern recognition receptors in recognition of bacteria
and viruses,” “interferon signaling,” and “acute phase response
signaling” (Table 2), conﬁrming the primary function of this module as immune response. Upon further inspection of module members that also participated in these pathways, many are members of
the interferon response pathway (e.g., Oas1, Oas1b, Oas2, Oas3,
Eif2ak2, and Iﬁh1) which is the primary pathway activated upon viral infection (Kawai and Akira 2006, 2007).
359
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Table 1.

Top Five IPA enriched canonical pathways for module 7 (m7, lipid biosynthesis)
P-value

IPA canonical pathway
Role of macrophages, ﬁbroblasts and endothelial cells in
rheumatoid arthritis
Superpathway of cholesterol biosynthesis
Interleukin-1 (IL-1) signaling
Actin cytoskeleton signaling
Regulation of the epithelial-mesenchymal transition pathway

3.89 × 10

−6
−6

8.13 × 10
3.89 × 10−5
8.32 × 10−5
1.58 × 10−4

Genes
Cebpg, Fgf2, Fzd9, Il17ra, Il33, Irak2, Irak3, Nfkbie, Plce1, Rap1b, Rhoa,
Ripk1, Stat3, Tcf7l1
Dhcr24, Dhcr7, Hmgcs1, Hsd17b7, Idi1
Gna12, Gna13, Gng12, Irak2, Irak3, Nfkb2, Nfkbie
Cyﬁp1, Fgd3, Fgf2, Gna12, Gna13, Gng12, Gsn, Rap1b, Rhoa, Wasf2
Fgf2, Fgfrl1, Fzd9, Hgf, Nfkb2, Rap1b, Rhoa, Stat3, Tcf7l1

Genetic mapping of m7 module eigengene identifies
Fgf2 as a regulator of m7 and short-term memory
outcomes

Molecular subnetworks for m5 implicate specific immune
pathways and genes as modulators of long-term memory
outcomes

A major advantage of using genetic reference panels to model polygenetic disorders is the ability to perform genetic mapping of complex traits for such disorders, including measures of module
expression, to identify chromosomal regions and genes within
them that regulate these traits. To identify chromosomal regions
regulating module expression we performed quantitative trait
loci (QTL) mapping of module eigengenes for all cognitive relevant
modules (Fig. 4; Supplemental Table S4, depicted as green triangles). Speciﬁcally, we focused on identifying chromosomal regions
regulating m5 and m7 expression, since these modules were identiﬁed through Bayesian modeling as being directly upstream of
cognitive outcomes. While we did not identify any QTLs for the
m5 eigengene, we identiﬁed a signiﬁcant QTL for the m7 eigengene, which fell in a small region on chromosome 3 (36.5–53.3
Mb), which means genetic variation within this region corresponds to variation in m7 expression (Fig. 5A). Within this region
of chromosome 3 we identiﬁed 45 protein coding genes, only one
of which was a member of m7, Fibroblast growth Factor 2 (Fgf2),
identifying this gene as a possible regulator of m7 expression and
activity. Investigation of the variants in Fgf2 between C57BL/6J
and DBA2/J in the Sanger Mouse Genomes database highlighted
many single nucleotide polymorphisms (SNPs) between the two
strains, the most notable being a possible splice donor and/or missense variant (Keane et al. 2011). Additionally, our data show that
hippocampal Fgf2 expression is signiﬁcantly higher in strains that
carry the B allele compared to strains that carry the D allele at the
marker SNP closest to the Fgf2 gene body (Fig. 5B). Finally, we
found that Fgf2 expression signiﬁcantly negatively correlated
with Y-maze working memory outcomes in strains that carried
the B allele at Fgf2, but carried no signiﬁcant relationship with
mice that carried the D allele at Fgf2 (Fig. 5C). Comparatively,
Fgf2 expression in all strains signiﬁcantly negatively correlated
with CFA short-term memory outcomes (Fig. 5D). Together, this
genetic mapping nominated a candidate by which m7 expression
and possibly activity is controlled, and further experiments will
determine the exact role by which Fgf2 may control memory outcomes during aging and AD.

Since a large number of genes (848 genes) fell into m5, the module
directly upstream of CFM long-term memory outcomes in the
Bayesian network, we conducted a subclustering analyses to resolve smaller molecular networks that may exist within the larger
module. Speciﬁcally, we performed SpeakEasy clustering analysis
on gene expression measures from m5 members, and identiﬁed
ﬁve distinct subclusters (SCs) within m5 (Fig. 6A; Supplemental
Table S5). GO enrichment of the genes within each SC revealed immunological pathways as the top enriched GO term, such as response to virus (SC1), lymphocyte differentiation (SC2), acute
inﬂammation (SC3), Interleukin-8 (IL-8) secretion (SC4), and acrosome reaction (SC5) (all enriched GO terms in Supplemental Table
S6). Spearman correlation of each SC to CFA slope short-term
memory and CFM long-term memory outcomes highlighted signiﬁcant negative module-trait correlations for each SC except for
SC5, which was only correlated with long-term memory outcomes
(Fig. 6B). Furthermore, SC1: response to virus, SC3: acute inﬂammation and SC4: IL-8 secretion explained comparable variance in
CFA slope short-term memory outcomes to m5 expression (Fig.
6C), while SC3 and SC4 explained comparable variance in longterm memory outcomes to m5 expression (Fig. 6D). Finally, while
the m5 eigengene alone did not map to a QTL, we identiﬁed six
QTLs for the SC5 eigengene (Fig. 6E; Supplemental Table S4).
The m5 gene members within these regions were enriched for immune functions, suggesting regions of the genome that contain
genes associated with immune function could also be important
for regulating how m5 controls long-term memory outcomes,
since SC5 was also correlated with long-term memory.
Furthermore, when we investigated how m5 SCs were genetically
controlled in the AD-BXD population, we found that the SC5
eigengene mapped to a smaller region on chromosome 1 that overlapped with the QTL we identiﬁed in Figure 6E (Supplemental Fig.
S5C; Supplemental Table S4). This region of chromosome 1 was
also enriched for m5 members associated with the interferon response pathway (Iﬁ204, Iﬁ202b), adaptive immune response
(Exo1, Fcrl6) and glia signaling (Kcnj10) (Supplemental Fig. S5D).
Together, this subclustering analysis further elucidates the overall

Table 2.

Top ﬁve IPA enriched canonical pathways for module 5 (m5, immune: virus)

IPA canonical pathway

P-value
−12

Role of pattern recognition receptors in
recognition of bacteria and viruses
Systemic lupus erythematosus in B cell
signaling pathway

3.98 × 10

Interferon (IFN) signaling
Th1 and Th2 activation pathway

1.62 × 10−9
8.32 × 10−9

Acute phase response signaling

1.70 × 10−8

www.learnmem.org

1.00 × 10

−10

Genes
C3, Ccl5, Cntf, Ddx58, Eif2ak2, Faslg, Iﬁh1, Il18, Il1a, Il21, Irf7, Ltb, Myd88, Nod2,
Oas1, Oas1b, Oas2, Oas3, Ptx3, Tlr3, Tlr6, Tnf, Tnfsf10, Tnfsf12
Cd72, Cd79a, Cd79b, Cntf, Faslg, Iﬁh1, Iﬁt2, Iﬁt3, Ighm, Il18, Il1a, Il21, Irf7, Irf9, Isg15,
Isg20, Lilrb3, Ltb, Myc, Myd88, Pik3ap1, Rras, Shc1, Stat1, Stat2, Tlr3, Tnf, Tnfsf10,
Tnfsf12, Traf1
Iﬁ35, Iﬁt3, Iﬁtm3, Irf1, Irf9, Isg15, Oas1, Socs1, Stat1, Stat2, Tap1
Acvr1c, Aph1a, Cd274, Cd28, Cd3d, Cd3e, Cd3g, Cd8a, Cxcr6, Icam1, Icos, Il18, Il2rb,
Irf1, Jak3, Klrd1, Socs1, Socs3, Stat1, Stat4, Stat6
A2m, C1r, C1s, C3, Hpx, Il18, Il1a, Il1rn, Itih3, Map2k3, Myd88, Rras, Serpina3,
Serpinf1, Serpinf2, Serping1, Shc1, Socs1, Socs3, Tnf, Tnfrsf11b
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B

C

D

Figure 5. Mapping of the module upstream of working memory and short-term memory measures identiﬁes Fgf2 as a potential driver. (A) Genetic
mapping of m7 using the ﬁrst principal component (PC1) as module eigengene. Age, sex, and FAD mutation status were used as additive covariates.
(B) Stratiﬁcation of Fgf2 expression based on genotype at the closest marker single nucleotide polymorphism (SNP) to Fgf2 genetic location (Student’s
t-test, P < 0.05). (C) Fgf2 expression is signiﬁcantly correlated (Spearman, P < 0.05) with overall working memory performance only in mice with the
B/B genotype at the marker SNP closest to Fgf2 but not with B/D. (D) Fgf2 expression is signiﬁcantly correlated (Spearman, P < 0.05) with overall short-term
memory performance in mice with either the B/B or and B/D genotype at the marker SNP closest to Fgf2. Signiﬁcant correlations denoted by red asterisks.
NS = no signiﬁcant correlation.

function of m5 for viral and adaptive immune response, and nominates a region on chromosome 1 that could be important for controlling m5 expression. Future experiments will deduce the
function of this genetic region, and how genes within may control
m5 expression and possibly long-term memory outcomes.

modules continued to be correlated to cognitive outcomes in the
AD-BXD population, including m5 (immune: virus) and m7 (lipid
biosynthesis), which were the modules directly upstream of cognitive outcomes in the Bayesian model (Fig. 7A; Supplemental Table
S7). This supported the hypothesis that the presence of amyloiddriving mutations strengthens the module-–trait relationships
that explain a portion of the individual differences in cognitive
outcomes.
To determine the degree to which the seven signiﬁcant module–trait relationships within the AD-BXD population were dependent on the amount of brain amyloid (Fig. 7A), we quantiﬁed the
amount of variance that cortical amyloid load explained for each
cognitive measure within the AD-BXD population (Aβ1-42 ELISA
assay previously reported in (Neuner et al. 2019a)). Cortical
Aβ1-42 (ng/mg total protein) explained 3.5% of working memory
(not statistically signiﬁcant), 9.0% of short-term memory (P <
0.05), and 14.3% of long-term memory outcomes (P < 0.01) (Fig.
7B). For several modules Aβ1-42 could explain a large amount of
the variance in module expression, such as 29.4% of the variance
in m4 expression, and 26.3% of the variance in m7 expression (P
< 0.01) (Fig. 7C). This suggested that Aβ1-42 likely inﬂuences the
expression of modules within AD-BXDs.
To test the degree to which cortical Aβ1-42 modulated the effect of each module (as measured by average expression) had on
each cognitive domain, we generated linear models for each significant module–trait relationship, with the addition of cortical
Aβ1-42 ELISA measures as a second independent variable within
the model. We ﬁrst used Type 3 ANOVA statistical tests to obtain

The effect of module expression on AD-BXD long-term
memory outcomes is partially modulated by amyloid
accumulation
While the previous analyses were performed on the combined
AD-BXD and Ntg-BXD population that contained individual
strains that did not carry amyloid-driving mutations, many of
the networks explaining large variance in cognition, such as inﬂammation (m4 and m5), related to pathways previously implicated in the etiology of AD. To evaluate how the presence of the
5XFAD transgene affected module expression, we used three-way
ANOVA tests on module expression, and found that 11 of the 16
cognitively relevant modules were signiﬁcantly affected (adj. P <
0.05) by presence of the 5XFAD transgene (Supplemental Fig.
S1), suggesting that the presence of amyloid-driving mutations accounts for the majority of the signiﬁcant module-–trait relationships. To test if module–trait relationships were primarily driven
by the presence of FAD mutations, we recalculated the module–
trait Spearman correlations of the 16 cognitively relevant modules
for the Ntg-BXD and AD-BXD populations separately. While there
were no signiﬁcant module-trait correlations in the Ntg-BXD population, we found that 7 of the 16 original cognitively relevant
www.learnmem.org
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cumulation (Fig. 7D). This was similar for
CFA short-term memory outcomes, except the relationship of m6 to CFA slope
was signiﬁcantly improved by the addition of Aβ1-42 accumulation into the linear model (Fig. 7E). One thing to note is
that the effect of m7, the module upstream of working memory and shortterm memory in the Bayesian model
(Fig. 4), on cognitive outcomes was not
D
C
improved by the addition of Aβ1-42 accumulation to the linear model, suggesting
a nominal role for how amyloid inﬂuences these module–trait relationships.
Finally, for CFM long-term memory outcomes, the effect of all except for two
modules (m4, m7) was signiﬁcantly improved by the addition of Aβ1-42 into
the linear model, suggesting that amyloid
may play a more direct role on inﬂuencing the module–trait relationships for
modules associated with long-term memF
E
ory (Fig. 7F). Additionally, all except one
of the m5 SCs were signiﬁcantly improved by the addition of Aβ1-42 into
the linear model (Supplemental Fig. S5A,
B), suggesting that the speciﬁc relationship between m5 (and subsequent SCs)
and long-term memory outcomes are inﬂuenced by amyloid accumulation. To
gain a further understanding of the
age-related factors that could drive
these relationships, we recreated linear
models within 6 mo AD-BXDs and 14
mo AD-BXDs (Supplemental Fig. S6).
Interestingly, while the majority of the
variance for working memory and shortterm memory outcomes were observed
within the 6 mo AD-BXD cohort, module
expression explained more variance in 14
mo AD-BXDs for long-term memory outFigure 6. Subclustering of the m5 immune module identiﬁes ﬁve subclusters with immune function
comes (Supplemental Fig. S6C–E). This
and QTLs that map to immunologically relevant genetic regions. (A) Composition of m5 based on subindicates that early-in-life perturbation
cluster (SC) gene membership; for the 848 genes in m5 the subclusters broke out into 291 genes in SC1,
of m7 at 6 mo or earlier may have a greater
228 genes in SC2, 176 genes in SC3, 108 genes in SC4, and 45 genes in SC5. (B) Spearman correlations
(adj. P < 0.05) of m5 and SC1–SC5 to short-term and long-term memory measures. (C,D) The proporeffect on altering working and short-term
tion of variance in measures for short-term memory (C) and long-term memory (D) explained by m5
memory cognitive domains, while pertur(dark red) and SC1-SC5 (light red) average expression. For B–D SCs are denoted by the most signiﬁcantly
bation of m5 at a later age (14 mo) may
enriched GO term. (E) Genetic mapping of the ﬁrst principal component (PC1) as module eigengene for
prove more successful to improve the
SC5; Age, sex, and FAD mutation status were used as additive covariates. (F ) Table denoting proteinlong-term memory cognitive domain.
coding genes symbols, ensemble IDs, and chromosomal location for each gene within the SC5 QTL
Together, these ﬁndings suggest a speciﬁc
peaks that were also m5 members.
role of the interaction of cortical Aβ1-42
accumulation and module expression on
inﬂuencing long-term memory outcomes, while a more indirect
signiﬁcant module-Aβ1-42 interactive effects on cognitive outor nominal role of Aβ1-42 accumulation on inﬂuencing how modcomes that identiﬁed only one module-Aβ1-42 relationship (m4)
ules affect working memory and short-term memory outcomes.
had a signiﬁcant interactive effect on Y-maze %SA (Supplemental
Table S8). Since only a single interactive effect was obtained, we
tested the additive effect of module expression and cortical
Cognitively relevant mouse modules replicate in aged
Aβ1-42 accumulation using Type 2 ANOVA statistical tests
human molecular brain networks
(Supplemental Table S8), as well as likelihood-ratio (LRT) tests to
determine if the addition of amyloid into the model signiﬁcantly
A criticism of using mouse models for AD research is that many preimproved the linear ﬁt that explained cognitive outcomes using
vious ﬁndings in mouse models have failed to translate to human
module expression (Satorra and Saris 1985). Within AD-BXD indipatients. Therefore, we tested the replication of all mouse coexpresviduals, module expression for each signiﬁcantly correlated modsion modules in human brain data, including those predicted to be
ule explained up to 10% of the variance in Y-maze working
upstream of variation in cognitive outcomes across our mouse popmemory %SA outcomes, and the models for this cognitive outulation. Using a consensus genetic clustering analysis of dorsolatcome were not signiﬁcantly improved by the addition of Aβ1-42 aceral prefrontal cortex (DL-PFC) from aged individuals (AD and

A
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due to its mixture of innate immune response genes and cell cycle genes. We
also tested the conservation of molecular
networks generated by a meta-analysis of
multiple brain regions from human aged
and AD tissue (Wan et al. 2020), and
found that all 16 signiﬁcantly correlated
mouse modules in at least one brain
gene network (Supplemental Fig. S7).
Speciﬁcally, all of the signiﬁcantly correlated mouse modules were conserved in
the DL-PFC molecular networks from
the Accelerating Medicines PartnershipAlzheimer’s Disease (AMP-AD) consortium meta-analysis molecular networks,
strengthening our ﬁndings from the conservation with the Mostafavi DL-PFC networks. Notably, the two prioritized
modules from our Bayesian analysis (m5
and m7) were both signiﬁcantly conserved with several human modules associated with cognitive function across the
population (Fig. 8; Supplemental Fig.
S7). These results highlight that both
the major molecular networks and ontology pathways observed in a genetically
diverse mouse population are also replicated in human cohorts, making our current ﬁndings prioritizing m5 and m7
relevant to human AD and aging
populations.

A

B

C

E

F

D

Discussion

Figure 7. AD-BXD long-term memory module–trait relationships are impacted by the amount of
amyloid accumulation. (A) Average standardized module expression for 5XFAD mice was correlated
to cognitive traits to identify modules that signiﬁcantly modify cognitive function in the AD-BXD
mouse population. Only the modules that were signiﬁcantly correlated with cognitive function in the
entire population were tested for signiﬁcant relationships within the AD-BXD cohort. Modules with
no signiﬁcant correlation to corresponding cognitive outcome are depicted in white. (B) The proportion
of variance in cognitive outcomes explained by amount of cortical amyloid (quantiﬁed by
Aβ1-42-speciﬁc sandwich colorimetric ELISA) in AD-BXD mice. (C ) The proportion of variance in
module expression explained by amount of cortical Aβ1-42. (D–F) The proportion of variance in measures for working memory (D), short-term memory (E), and long-term memory (F) explained by
module expression and amount of cortical Aβ1-42 in AD-BXD mice, using an additive Type 2 ANOVA
model. Variance explained by individual modules signiﬁcantly positively (blue) and negatively (red) correlated to corresponding cognitive trait are in lighter colors, while amount of variance explained by
amyloid as part of the additive linear model is in darker colors. Likelihood-ratio (LRT) tests were performed for each model to test if the addition of cortical Aβ1-42 into the additive model generated a
better ﬁt of linear model. Signiﬁcant P-values (P < 0.05) of LRT tests are denoted by black asterisks, indicating the addition of cortical Aβ1-42 to the model provides a better linear ﬁt than module expression
alone. All modules are annotated by the most signiﬁcantly enriched GO term (NS GO = no signiﬁcant GO
enrichment).

The search for the underlying genetic and
molecular causes of AD cognitive decline
has been the primary goal for identifying
and developing therapeutics for several
decades (Graham et al. 2017). Identiﬁcation of such genetic and molecular mechanisms that inﬂuence AD symptoms
using preclinical mouse models has been
criticized because of the poor translatability of ﬁndings in mouse models to effectively treating human AD (Onos et al.
2016; Drummond and Wisniewski
2017). Modeling the disease in more genetically diverse mice may be one avenue
to improve the construct validity of preclinical models (Hyman and Tanzi 2019;
Neuner et al. 2019a). Using this model,
we were able to leverage transcriptomic and phenotypic information from pre- and postsymptomatic mice with and without AD
mutations to identify the molecular networks that are predicted
to directly inﬂuence variation in cognitive outcomes across a population. We found many sets of coexpressed genes, each representing the activity of one or more molecular systems, that were
signiﬁcantly correlated with population-wide differences in cognition, and explained up to 30% of the variance in cognitive outcomes. This is important because while high-impact variants

non-AD) (Mostafavi et al. 2018), we performed statistical hypergeometric tests to see how well our mouse modules overlapped with
those found in humans. We found that the majority (15/16) of
the cognitively relevant mouse modules were signiﬁcantly (adj. P
< 0.05) conserved in human DL-PFC modules (Fig. 8). The only
nonconserved module was m6 (immune/cell cycle), which was surprising since indicators of inﬂammation are consistently observed
in AD tissue. However, other immune-related modules were conserved, while the lack of conservation for this module may be
www.learnmem.org
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because therapeutically targeting RhoA
pathways has been found to be promising
for improving AD and mixed dementia
symptoms, proposing a method by which
targeting m7 could inﬂuence AD cognitive outcomes (Herskowitz et al. 2013;
Gentry et al. 2016; Henderson et al.
2019). While these previous studies have
investigated RhoA pathway inhibition in
the context of amyloid and tau pathology
in AD and mixed dementia, these ﬁndings could suggest that inhibition of m7
via the RhoA pathway could also improve
cognitive outcomes. Additionally, our
IPA analysis identiﬁed other pathways of
interest, such as “IL-1 signaling,” and
“cholesterol biosynthesis.” IL-1 signaling
Figure 8. Mouse modules signiﬁcantly associated with cognitive outcomes have high degree of conin astrocytes plays an important role in
servation to human AD modules. Mouse modules signiﬁcantly correlated to cognitive measures (left,
y-axis) were examined for gene conservation in previously established (Mostafavi et al. 2018) aged/
promoting inﬂammation. IL-1 signaling
AD human dorsolateral prefrontal cortex (DL-PFC) modules (top, x-axis). Modules are colored based
deﬁciency has also been demonstrated
on positive (blue) or negative (red) correlation to corresponding mouse (working/short-term/long-term
to have detrimental effects on hippocammemory) or human (slope of decline) cognitive measure. Heatmap depicts degree (measured by −log
pal synaptic plasticity (Moynagh et al.
[adj. P-value]) of overlap (hypergeometric test) between human and mouse modules. Only signiﬁcant
1994; Ben Menachem-Zidon et al. 2011).
(adj. P-value <0.05) overlaps are depicted, while nonsigniﬁcant overlaps are white. Human modules
As the IL-1 signaling pathway is also an
were excluded if they did not overlap with at least one mouse module tested above. Mouse modules
are denoted by the most signiﬁcantly enriched GO term.
indicator of inﬂammation, the overall
representation of this module could be
for reactive (or A1) astrocytes, which
such as those in APOE can explain a considerable proportion of AD
have been widely described as being induced by inﬂammatory inrisk, many of the more common AD variants have much smaller
sult (Zamanian et al. 2012; Anderson et al. 2016; Liddelow et al.
effect-sizes making new gene targets less impactful for translation
2017). More speciﬁcally, reactive astrocytes are thought to be into larger populations (Bertram et al. 2007; Genin et al. 2011; Mosduced by proinﬂammatory cytokines TNFα, IL-1, and C1Q, which
tafavi et al. 2018). In contrast, the upstream molecular networks
are highly expressed in microglia in the CNS (Zhang et al. 2014;
identiﬁed here explain larger variances and may have a much largBennett et al. 2016). Two of the three transcripts for these cytoer effect on improving cognitive outcomes on the population levkines appear in m5 (Tnf, Il1a), suggesting an interplay between
els. The networks consistently explaining the most variance were
these two modules and representative cell-types that directly inﬂuenriched for viral and myeloid immune pathway genes (m4, m5,
ence cognitive resilience. Finally, an indicator of inﬂammation
m6), as well as lipid and coenzyme metabolism pathway genes
that has been characterized in astrocytes and microglia is the for(m7, m8). Additionally, genes within these biologically signiﬁcant
mation of lipid droplets within these cells, which synthesizes
modules were found to be primarily expressed in nonneuronal cellwith our other ﬁnding of additional enrichment of lipid metabotypes such as astrocytes and microglia, suggesting that regulation
lism pathway genes in this module (Farmer et al. 2019;
of the speciﬁc pathways [lipid biosynthesis, IL-1 signaling, interferMarschallinger et al. 2020).
on (IFN) signaling] within these cell-types contributes most sigIn addition to the interesting proinﬂammatory pathways, the
niﬁcantly to divergent cognitive outcomes across resilient and
“cholesterol biosynthesis” pathway present in m7 suggests an adsusceptible individuals (Zhang et al. 2014). These observations
ditional mechanism by which astrocytes may dictate cognitive
were further substantiated by our Bayesian modeling of module–
outcomes. Cholesterol biosynthesis has been previously implicattrait relationships in that the only modules directly upstream of
ed in AD pathogenesis due to a variety of mechanisms. For examcognitive outcomes were enriched for nonneuronal genes: the asple, cholesterol inﬂuences the relationship between amyloid
trocyte lipid biosynthesis module (m7) for working and short-term
precursor protein (APP) and in the production of Aβ, but the mechmemory, and the microglia viral immune module (m5) for longanism by which this occurs is still not understood well (Shobab
term memory. This model proposed two cell-type enriched molecet al. 2005). In addition, cholesterol biosynthesis is of particular
ular networks to prioritize for further investigation, since our modimportance to mature neurons since astrocytes are the primary
el predicted that population-wide differences in these networks
cholesterol source for mature neurons in the CNS (Poirier et al.
have greatest direct impact on regulating cognitive outcomes.
1993; Pfrieger 2003). A negative association between lipid biosynthesis and cognitive outcomes could indicate a stall or dysfunction
in this process by either depriving neurons of necessary lipids or
Targeting astrocyte lipid biosynthesis and IL-1 signaling
over-production within astrocytes. Finally, APOE- the most signiﬁmay promote resilience to working memory and
cant risk factor for sporadic AD- is also intimately involved in choshort-term memory decline
lesterol metabolism. Risk variants in APOE have been hypothesized
to disrupt the ability of APOE to bind cholesterol and therefore
The gene network that our model found to be directly upstream of
contribute to AD pathogenesis (de Chaves and Narayanaswami
working and short-term memory was m7, which was enriched for
2008; Wood et al. 2014). As the BXD panel contains naturally oc“lipid biosynthesis” GO biological pathways. Notably, m7 was excurring variation in the Apoe receptor binding domain, this study
clusively enriched for genes found in astrocytes, speciﬁcally, implimay have identiﬁed the cell-type and pathway by which Apoe inﬂucating astrocytic lipid biosynthesis as critical for determining
ences cognitive resilience (Arboleda-Velasquez et al. 2019; Neuner
cognitive outcomes. Further IPA analysis also highlighted a notaet al. 2017, 2019a). Further studies will be conducted to (1) test if
ble m7 gene, Rhoa, that emerged in three of the ﬁve top enriched
lipid biosynthesis is higher in astrocytes from mice that perform
canonical pathways (Table 1). This gene is of particular interest
www.learnmem.org
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worse on short-term and/or working memory cognitive tasks using
pulse-chase experiments (Rambold et al. 2015; Thiele et al. 2019),
and (2) observe if the IL-1 inﬂammatory signature from this module synthesizes with lipids by evaluating lipid droplet formation
within astrocytes from AD-BXD individuals using BODIPY staining
(Li et al. 2020). These experiments will further our understanding
of the contribution of speciﬁc pathways we believe to be involved
in astrocytes that help dictate AD cognitive outcomes.

mune: myeloid module, and not m5, our immune: virus module.
It was interesting that several high impact sporadic AD genes
(BIN1, TREM2, APOE) were present in a single module (we allowed
discrete assignment of each gene to one module in this study), and
also that this module did not explain as much variance in cognitive
outcomes as the viral immune pathway, with m4 explaining 6.6%
and m5 explaining 10.5% of the variance in long-term memory
(Fig. 3). It could be possible that these m4 LOAD genes and immune: myeloid pathways in m4 have a more indirect effect on
AD cognitive resilience as a molecular system, compared to the viral immune response pathway.
Given recent evidence that viral immune pathways, including
the type-1 interferon (IFN) pathway, are up-regulated in human AD
patients, the viral immune network identiﬁed in m5 is an interesting pathway associated with the neuroinﬂammatory response observed in AD (Taylor et al. 2014). Previous studies using mouse
models of AD have demonstrated that knockout of the type-1
IFN receptor (IFNAR), an important receptor for the viral immune
response, causes reduced amyloid monomer levels, and partial rescue of performance on the Morris water maze task at 9 mo of age
(Minter et al. 2016). Recently, conﬂicting evidence has emerged
about the implications of viral infections, such as the presence of
herpesviruses (HSVs, HHVs) in postmortem brain tissue, with AD
cognitive deﬁcits (Allnutt et al. 2020; Readhead et al. 2018).
While these infections would not be present in the mice used in
this study, since they are raised and aged in a controlled lowpathogen environment, it is interesting that we still observe activation of antiviral pathways. Additionally, we found very little overlap in m5 genes with genes that drive network activity of cells that
are infected with herpesviruses such as HSV-1 or HHV6A found in
AD patient brains (Readhead et al. 2018; Drayman et al. 2019). This
suggests that the networks activated by these viruses in human patients are independent of the viral immune pathways enriched in
m5, and that the m5 network represents an immune response to
nonviral pathological burdens present in the brain, such as Aβ.
This is supportive of our ﬁnding that the effect of m5 on long-term
memory outcomes was improved by the addition of cortical Aβ accumulation in the linear model. However, since the mice used in
this study have not been exposed to a systemic viral challenge, it
could be possible that activating antiviral pathways systemically,
by either HSV infection or poly I:C challenge, could activate other
molecular networks that explain more variance in long-term memory outcomes compared to those activated in mice raised in a sterile
environment. More work needs to be done in this ﬁeld to decipher
a speciﬁc interplay between environmental factors (such as viral
exposomes and diet), amyloid and the relevance of their interaction in AD pathogenesis (Dunn et al. 2019).
Along with viral immune pathways being represented in m5,
our subclustering analysis highlighted more distinct immune
pathways that continued to be correlated with long-term memory
measures (Fig. 6; Supplemental Fig. S5). The enriched pathways revealed by these subclusters further supported the importance of viral immune response pathways (represented in SC1), as well as
indicators of an adaptive immune response (lymphocyte differentiation represented in SC2), and microglial migration (represented
by IL-8 signaling in SC4). These pathways were interesting because
while the importance of viral immune pathways remained, we also
identiﬁed other pathways such as the IL-8 signaling pathway that
we would not have identiﬁed as the top enriched pathway in the
large m5 module. The IL-8 signaling pathway is interesting in the
context of AD because IL-8 (with the ofﬁcial gene symbol of
Cxcl8) is known to induce microglial migration, and has been previously found to increase in microglia exposed to amyloid (Lue
et al. 2001; Franciosi et al. 2005). Additionally, IL-8 has been proposed as a biomarker for AD cognitive impairment and cerebrovascular dysfunction when it was found to be up-regulated in blood

Fgf2 as a possible regulator of working and short-term
memory outcomes
In this study we leveraged the power of the known genetic composition of our AD-BXD panel to identify a chromosomal region, and
a protein-coding gene within, that regulates the expression of m7,
the module directly upstream of Y-maze working memory and CFA
short-term memory outcomes. The nominated gene, Fgf2, showed
a strong negative overall relationship of expression with short-term
memory outcomes. The FGF2 protein has a variety of known functions in the CNS, including promoting angiogenesis, neurogenesis, and improving symptoms of cognitive aging (Woodbury and
Ikezu 2014). FGF2 is primarily expressed in astrocytes in the adult
brain, but can also be secreted by neurons when damaged to produce a distress signal to recruit microglia and astrocytes to the
site of damage (Reuss and von Bohlen und Halbach 2003; Noda
et al. 2014). Functionally, FGF2 is known to regulate the proliferative response to oligodendrocyte precursor cells (OPCs) during
remyelination of axons after acute demyelination injury, suggesting another role of FGF2 signaling in regulating glia-neuron homeostasis (Frost et al. 2003; Magy et al. 2003; Murtie et al. 2005).
Experimentally induced spinal cord and CNS injury has shown
to promote reactive astrogliosis, and these reactive astrocytes
have been previously shown to up-regulate FGF2, suggesting an additional involvement of FGF2 in the proliferation and reactivity of
astrocytes to sites of injury and recovery (Fahmy and Moftah
2010). Increased FGF2 (or basic FGF, bFGF) has been observed in reactive astrocytes and the neurons surrounding amyloid plaques, as
well as its localization to neuroﬁbrillary tangles and cerebrovascular deposits in AD patient brain tissue (Gomez-Pinilla et al. 1990;
Stopa et al. 1990; Cummings et al. 1993). However, delivery of
FGF2 into the hippocampus of APP mice using AAV2/1 viral construct caused mice to show enhanced long-term potentiation, reduced Aβ production, and enhanced neurogenesis, suggesting
FGF2 can act to halt AD pathophysiology (Kiyota et al. 2011).
Together, while our data suggest that more Fgf2 is detrimental to
cognitive performance, other data suggest FGF2 activity is important to glial and neuronal response to injury or pathological environment. However, characterization of bFGF with AD pathology
suggests it could be part of the reactive astrocyte response to disease
activity. Further work will have to be conducted to determine the
cell-type for which Fgf2 is promoting a negative correlation with
cognitive outcomes, the cellular pathways by which it is acting,
and how it could be detrimental to AD cognitive outcomes.

Targeting viral and adaptive immune pathways to promote
long-term memory resilience
The robust associations of microglia and microglial processes with
improving cognitive outcomes in mice is consistent with genetic
(Lambert et al. 2013; Kunkle et al. 2019) and cellular data (Sosna
et al. 2018; Spangenberg et al. 2019), indicating their relevance
to AD disease activity and cognition (Hong et al. 2016; Kinney
et al. 2018). Surprisingly, when we interrogated our molecular networks in search of known AD risk genes enriched in immune
processes, we found that the majority of the sporadic AD
immune-related risk genes were actually present in m4, our imwww.learnmem.org
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serum of AD and cognitively impaired individuals with cerebrovascular disease compared to noncognitively impaired counterparts
(Zhu et al. 2017). Therefore, enrichment of this pathway could
be a possible indicator of population-wide differences in microglial
amyloid migratory response, and differences in cerebrovascular
dysfunction across the AD population. We also may have identiﬁed a measurable marker of resilience and susceptibility to cognitive impairment by identiﬁcation of this m5 subcluster which we
will test in future studies for validation. Finally, subclustering of
m5 also allowed for genetic mapping of the SC5 eigengene to a region on chromosome 1 within the AD-BXD population (Fig. 6E,F;
Supplemental Fig. S5C,D). This region was interesting because several genes within this locus were also m5 members, and associated
with IFN signaling (Iﬁ204, Iﬁ202b), adaptive immune response
(Exo1, Fcrl6), and a glia-speciﬁc potassium channel, Kcnj10 (also
known as Kir4.1). The region identiﬁed on chromosome 1 is incredibly interesting because of its enrichment for these glia and
immune-related genes that were also m5 members, as well as inspection of these genes with the Sanger Mouse Genomes database
reveals several coding variants between C57BL/6J and DBA/2J mice
(Keane et al. 2011). Additionally, SC5 was only signiﬁcantly correlated with long-term memory outcomes, suggesting a speciﬁc role
of this SC on integrating overall m5 activity with individual differences in long-term memory outcomes. Future work will elucidate
how this SC5 molecular network, the chromosome 1 QTL, and
the genes within it possibly control overall m5 activity and longterm memory outcomes.
Overall, our data and suggest that the speciﬁc pathways that
will have the greatest impact on improving cognitive outcomes
are those involved in the microglial viral immune and migratory
response. It is still unclear if this module is representative of the local brain immune response by activation of microglia, or if this
pathway is also comprised of inﬁltrating immune cells that can
also contribute to the neuroinﬂammatory response in later stages
of AD, which was proposed by the enrichment of lymphocyte differentiation genes in m5 SC2 (Heppner et al. 2015). Additionally,
the distinction between peripheral and local neuro-immune responses in the brain are difﬁcult since microglia and peripheral
macrophages express many of the same marker genes and proteins.
Although our Bayesian model has found that the neuroinﬂammatory response is the major contributor to long-term memory resilience in our aging model, further experiments will be done to
distinguish how much of this resilience network is dictated by
peripheral or local innate immune responses. This will include
investigating the role of the systemic immune system, and how increased inﬁltrating systemic immune cells (CD4+ T cells, B cells, peripheral macrophages) may play a negative role in cognitive
resilience by evaluating brain gene and protein expression of these
peripheral markers in this mouse population and comparing to
TMEM119+ microglia. Speciﬁcally, we hypothesize from these
data that inhibition of the type-1 IFN signaling pathway in more
susceptible mice will promote cognitive resilience by delaying
the neuroinﬂammatory response that causes cognitive decline in
AD. Additionally, we will further investigate the role of IL-8 as a
possible biomarker of neuroinﬂammatory activity in susceptible
AD individuals. Finally, we have proposed several gene candidates
from QTL mapping of the m5 SC5 eigengene that we will examine
as possible targets to promote resilience to AD long-term memory
deﬁcits.

1991). It is still widely debated if amyloid is directly involved in determining AD cognitive trajectories, or if it is more of associated pathology with limited involvement in cognitive decline (Murphy
and LeVine 2010). We previously found in our AD-BXD population that while cortical Aβ1-42 levels were variable across genetic
backgrounds (especially at 14 mo), this variability did not directly
correlate with cognitive function (Neuner et al. 2019a). Here, we
found that many of our identiﬁed module–trait relationships
were strengthened when we isolated and tested these relationships
in the AD-BXD population (Supplemental Table S4; Fig. 7A), indicating the presence of FAD mutations is necessary for these molecular networks to inﬂuence cognitive outcomes. Using additional
linear modeling, we tested the effects of cortical Aβ1-42 accumulation on module expression, and if it could improve the inﬂuence of
module expression on cognitive outcomes. Our results indicated a
domain-speciﬁc effect that working memory and short-term memory were primarily inﬂuenced by module expression, and largely
independent of individual differences in amyloid burden (Fig.
7D,E). However, for long-term memory cortical Aβ1-42 accumulation improved the effect of module expression on memory outcomes, indicating an indirect role of amyloid on cognition
through inﬂuencing module expression (Fig. 7F; Supplemental
Fig. S5B). Therefore, we hypothesize that the role of Aβ on AD cognitive trajectories could be more complex than initially anticipated, and dependent on the cognitive domain and molecular
pathway. It is possible that more module variance could be explained if we had measured and compared hippocampal Aβ1-42 accumulation to gene expression changes instead of cortical Aβ1-42,
and are working to test this difference in future studies using
Aβ1-42 staining of ﬁxed hemibrains from the same mice investigated here. Further studies will also test this model to see how perturbation of certain molecular networks inﬂuences cognitive
outcomes, and if these networks will alter amyloid accumulation
or if secondary amyloid targeting is also needed to have maximum
effect, especially for long-term memory outcomes.

Advantages of diverse mice for defining the genetic origins
of resilience
In this study, we were able to leverage previously generated transcriptome and phenotype information from a population of genetically diverse mice to identify the molecular networks that directly
inﬂuence population-wide differences in cognitive outcomes. An
advantage of using a genetic reference panel such as the BXDs is
that we could leverage the well-deﬁned genetics of this population
to perform genetic mapping that anchored many of our module–
trait relationships.
In addition to identifying immune and lipid metabolism
pathways, as well as the Fgf2 gene, as being possible direct regulators of AD cognitive outcomes, this study also identiﬁed neuronal
and synaptic modules that were correlated to short-term memory
outcomes (see Fig. 3A). We wanted to highlight these neuronal
pathways in particular because recent studies using AD patient
brain tissue have found that changes in dendritic spine morphology can indicate resilience to AD cognitive decline (Boros et al. 2017,
2019). Further studies will test the importance of neuronal
pathways in providing AD resilience, especially in the context of
susceptible compared to resilient microglia or astrocyte environments, since targeting neuronal pathways have also been suggested to be desirable for therapeutic intervention in AD (Gentry et al.
2016; Henderson et al. 2019). Future work overlaying gene expression from mice that receive such interventions will also highlight
how these molecular networks interact with each other when a
speciﬁc module or target is perturbed. Finally, analysis of gene expression from this model system and comparison to human brain
networks has nominated conserved molecular systems that are

Elucidating the contribution of Aβ accumulation to the
impact of molecular networks on cognitive outcomes
As we have stated previously, AD is classiﬁed by progressive and
severe memory decline, as well as the pathological presence of
beta-amyloid (Aβ) plaques and neuroﬁbrillary tau tangles (Selkoe
www.learnmem.org

366

Learning & Memory

Downloaded from learnmem.cshlp.org on August 24, 2020 - Published by Cold Spring Harbor Laboratory Press

Molecular systems of cognitive resilience

relevant to diverse AD cognitive outcomes. The identiﬁcation
of these relevant molecular systems will lead to a better
understanding of preclinical models of human AD, which will allow for testing of novel resilience-based therapeutic strategies to
improve AD.

memory. AD-BXD and Ntg-BXD strain/age/sex speciﬁc group averages were generated for further downstream analyses.

RNA sequencing
Initial RNA sequencing (RNA-seq) of hippocampus from the
AD-BXD panel [6 mo, n = 71 (47 females/24 males) and 14 mo,
n = 86 (45 females/41 males)], and Ntg-BXD counterparts [6 mo,
n = 31 (17 females/14 males) and 14 mo, n = 33 (17 females/16
males)] has been previously reported ((Neuner et al. 2019a) GEO
accession number GSE101144; (Neuner et al. 2019b) GEO accession number GSE119215). Here, we expand upon this data set to
include RNA sequencing data from an additional 71 Ntg-BXD
mice, 27 of which were 6 mo of age (22 females/5 males) and 44
of which were 14 mo of age (28 females/16 males, GEO accession
number GSE119408). RNA-seq was performed as previously described (Neuner et al. 2019a). Brieﬂy, all samples were isolated using the Qiagen RNeasy Mini kit, libraries were prepared using
Truseq Stranded mRNA Sample Preparation Kit (Illumina Inc.),
and sequenced by 75 bp sequencing on an Illumina HiSeq2500.
Because sequencing was performed on mice harboring alleles for
C57BL/6J (B6) and DBA2/J (D2), the GBRS/EMASE pipeline
(Raghupathy et al. 2018) developed by the Churchill group at
The Jackson Laboratory was used in order to align reads to the correct allele, allowing for quantiﬁcation of both total reads for a gene
and reads assigned to the B6 or D2 allele. To account for the expression of the 5XFAD transgene, RNA-seq reads were additionally
aligned to the mutated human APP and PSEN1 sequences. Genes
were ﬁltered to require an average of at least 1 transcript per million
(TPM) in 50% of samples. RNA data was batch corrected using
ComBat (Johnson et al. 2007; Leek et al. 2012), and biological replicates were averaged together for downstream analyses. During
batch correction, two samples (S3 and S285) were included in
data upload, but dropped in ﬁnal analyses as outliers before strain
averaging. For ﬁnal downstream analysis, individual samples belonging to the same BXD strain/sex/age/mutation carrier group
were averaged to generate 156 distinct groups.

Materials and Methods
Bioethics
All mouse experiments occurred at University of Tennessee Health
Science Center and were carried out in accordance with the principals of the Basel Declaration and standards of the Association for
the Assessment and Accreditation of Laboratory Animal Care
(AAALAC), as well as the recommendations of the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals. The protocol was approved by the Institutional Animal
Care and Use Committee (IACUC) at the University of Tennessee
Health Science Center.

Animals
All data used in this study are from a mouse model of human AD,
the AD-BXD panel, which were previously described (Neuner et
al. 2019a). Brieﬂy, female B6 mice hemizygous for the 5XFAD
transgene (B6.Cg-Tg(APPSweF1LonPSEN1*M146L*L286V)6799Vas/
Mmjax, Stock No. #24848-JAX) were mated to males from the
BXD genetic reference panel (Williams et al. 2001; Peirce et al.
2004). One generation of breeding B6-5XFAD dams with BXD sires
results in a set of 26 isogenic F1 AD-BXD strains that either harbor
the 5XFAD transgene or are nontransgenic (Ntg)-BXD littermate
controls. Male and female AD-BXD mice were group housed as a
mix of 5XFAD and nontransgenic same-sex littermates and maintained on a 12 h light–dark cycle.

Y-maze
Behavioral testing to assess mice for working memory function was
performed as previously described (Neuner et al. 2019a). In brief,
mice were habituated to transport and to the testing room for 3 d
prior to testing. The y-maze test of spontaneous alternation was
performed for 8 min using a clear acrylic Y-shaped maze with
arms that were 2 inch wide × 12 inch long × 12 inch high (Oakley
et al. 2006; Neuner et al. 2019a). The maze was placed on a table
in a dimly lit room and spatial cues were displayed on walls around
the table. Mice were placed in a randomized start arm and video
tracking software was used to monitor arm entries (ANY-maze,
Stoelting Co.). An arm entry was called when the mouse’s entire
body, including the two back feet, entered the arm. The sequence
and total number of arms entered was recorded, and the percentage
of successful alternations was calculated as follows: number of alternations/maximum possible alternations (total number of arms
entered − 2) × 100. Mice were evaluated for performance on this
task longitudinally every 2 mo until their speciﬁed harvest age (6
mo or 14 mo). AD-BXD and Ntg-BXD strain/age/sex speciﬁc group
averages were generated for further downstream analyses.

Formation of gene coexpression modules
Consensus clustering was used on gene transcripts per million
(TPM) values from the RNA-seq results using a novel algorithm
(Gaiteri et al. 2015) to identify groups of coexpressed genes or
“modules” that represented genes that were commonly regulated
together across the examined mouse population. The consensus
clustering algorithm, SpeakEasy, was used to identify 31 discrete
transcriptional modules of coexpressed genes that ranged in size
between four to 1419 gene members. Twenty eight of the 31 modules contained more than 29 gene members, and could be assigned
for >99% of the genes analyzed for coexpression. Therefore, three
modules with fewer than 30 genes were excluded from downstream analysis, and contained <1% of total genes used for coexpression. This is consistent with previous methods for exclusion
of modules with small membership (Mostafavi et al. 2018).

Module functional enrichment
Gene Ontology (GO) functional enrichment analysis was performed on the genes within each module using the clusterproﬁler
package in R. GO categories with a hypergeometric enrichment adjusted P < 0.05 (adjusted for multiple comparisons using the
Benjamini Hochberg correction) were considered to be signiﬁcantly enriched within that corresponding module. Modules
were named using their corresponding number as well as the top
most signiﬁcantly enriched GO category.

Contextual fear conditioning
After 3 d of habituation to transport and to the testing room, mice
underwent contextual fear conditioning (CFC) as previously described (Neuner et al. 2015). On the ﬁrst day of CFC training,
mice were placed in a chamber and four 0.9 mA 1 sec (s) foot shocks
were delivered after a baseline period. Over the period of 700 sec
four foot shocks were delivered, and the postshock intervals were
deﬁned as the 40 sec following the offset of each foot shock. The
slope of the line formed when the percentage of time spent freezing following each shock was calculated as a function of each interval was used as a measure for contextual fear acquisition (CFA), and
short-term memory. Twenty-four hours after training, mice were
placed back into the training chamber and the percentage of
time spent freezing throughout the entire 600 sec test was measured as an index of contextual fear memory (CFM), and long-term
www.learnmem.org

Module cell-type enrichment
Genes in each module were evaluated for cell-type enrichment
from a previous study using a mineable set of genes obtained
from RNA-seq of sorted cells from the adult mouse cerebral cortex
(Zhang et al. 2014). The cell-type assignment for each gene was determined by identifying the max fragments per kilobase of transcript per million mapped reads (FPKM) for each gene in one of
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the seven cell populations included in the RNA-seq data set. Each
module was evaluated for enrichment using hypergeometric tests
to examine the overlap of module genes for genes in each cell
type. The list of 12,978 genes downloaded from brainrnaseq.org
was used as the background set, and module genes that had at least
one cell-type assignment were used. A Benjamini Hochberg correction for multiple comparisons was performed using the p.adjust()
function in R to obtain adjusted P-values of signiﬁcant overlap
from these tests.

Aβ1-42 ELISA to obtain a P-value which reﬂected if the two models
were signiﬁcantly different from each other. LRT tests with P < 0.05
were interpreted to have a better ﬁt with the addition of cortical
Aβ1-42 than with module expression alone. Results of ANOVA
analyses and LRT tests are depicted in Supplemental Table S8.

Module-trait network
The module-trait network was constructed using the predeﬁned relationships of modules that signiﬁcantly correlated with at least
one cognitive outcome, as well as genetic information provided
by quantitative trait locus (QTL) mapping of module eigengenes.
This module-trait network of mixed node times illustrated conditional dependencies among all variables (module expression, cognitive measures), and utilized genomic priors (genetic regions
associated with module eigengenes) to help determine the orientation of edges in the resulting network (Tasaki et al. 2015; Mostafavi
et al. 2018).

Identification of module–trait relationships
Pairwise correlation analysis was used to test the relationships between module expression and cognitive measures. First, the standardized average expression for each module was calculated
across all 156 strain/sex/age/mutation carrier group measures (setting average = 0, standard deviation = 1). To test the relationship of
modules to cognition, we performed Spearman correlation analysis
to identify the speciﬁc molecular networks that signiﬁcantly related to individual differences in cognitive outcomes. Using the
previously reported (Neuner et al. 2019a) cognitive measures for
each corresponding strain/sex/age/mutation carrier grouping,
Spearman correlations for module average expression to measures
for working memory (assessed using the Y-maze task), short-term
memory, and long-term memory (assessed using CFC) were calculated. We chose the Spearman correlation approach over Pearson
correlations because when we tested for normality of cognitive outcomes and module expression across the population, while cognitive outcomes were normally distributed (Supplemental Fig. S4),
module expression was not (Supplemental Table S9). Modules
that were signiﬁcantly correlated (Benjamini Hochberg adjusted
P < 0.05) with at least one of these three traits were selected for inclusion of downstream Bayesian direct acyclic graph analysis.

Module QTL mapping
Quantitative trait locus (QTL) mapping was performed using the
eigengene for each module signiﬁcantly correlated with cognitive
outcomes. Genotypes for the BXD strains used in this study were
obtained from GeneNetwork.org (Mulligan et al. 2017), and module eigengenes (ME) were generated by calculating the ﬁrst principal component (PC1) of module expression. The BXD genotypes
and module eigengenes were used for downstream QTL mapping
in r/qtl (Broman et al. 2003). ANOVA analyses of module expression (Supplemental Fig. S1) were used to establish age sex, and/or
genotype as additive covariates for each module. Covariates were
used as additive, and 1000 permutations were used to determine
statistical signiﬁcance. Results of all QTL mapping is depicted in
Supplemental Table S4.

ANOVA analysis of module expression on binary-coded
traits

Ingenuity pathway analysis
Ingenuity Pathway Analysis (IPA) was performed to complement
the initial GO enrichment for gene coexpression modules.
Speciﬁcally, the top enriched canonical pathways (by enrichment
P-value) in the IPA Canonical Pathway Analysis report were analyzed to gain a more speciﬁc understanding of enriched pathways
in modules.

Possible sources of variation in module expression were evaluated
using a Type 2 ANOVA as a function of mutation carrier + age + sex
(where mutation carrier denotes the presence/absence of the
5XFAD transgene) (Supplemental Fig. S1; Supplemental Table
S3). All P-values were adjusted using the Benjamini Hochberg correction for multiple comparisons.

Enzyme-linked immunosorbent assay (ELISA)

Calculation of variance explained

Data for beta-amyloid 1-42 (Aβ1-42) quantiﬁcation was used from
ELISA arrays performed and described in our previously published
study (Neuner et al. 2019a). Brieﬂy, Aβ1-42 levels were quantiﬁed
from sections of temporal cortex [6 mo n = 72 mice (46 female/46
male) across 22 AD-BXD strains, 14 mo n = 82 mice (43 female/33
male) across 21 AD-BXD strains]. Tissue was homogenized in 1×
PBS + 1% Triton X-100 using the TissueLyser II system (QIAGEN)
and sonicated 2 × 10 sec on low power. Protein concentration
was determined using a NanoDrop 2000 UV-Vis Spectrophotometer (ThermoScientiﬁc). Brain homogenates (10 mg/mL) were extracted in a ﬁnal concentration of 5 M GuHCl overnight at 4°C.
Samples were then diluted appropriately and run in duplicate on
Aβ1-42-speciﬁc sandwich colorimetric ELISAs according to the
manufacturer’s protocol (Cat# 298-92401, Wako Chemicals). Optical densities at 450 nm were read on a Biotek plate reader (BioTek)
and Aβ1-42 concentration was determined by comparison with
Aβ1-42 standard curves. Only readings in the linear range of the
standard curve were included in analysis. Duplicates were averaged
to determine concentration of Aβ1-42 in each sample. Finally,
Aβ1-42 concentrations were normalized to total protein concentration and are reported as nanograms of Aβ1-42 per milligrams of total protein.

Effect size was calculated by generating a linear model using the lm
() function in R, where formula = dependent ∼ independent. In this
formula, dependent variables corresponded to the cognitive measure for working memory (percent spontaneous alternations),
short-term memory (CFA slope), or long-term memory (percent
freezing during CFC testing, CFM), and the independent variable
was the standardized average expression for a speciﬁc module. A
Type 2 ANOVA was performed, and the variance explained was obtained by taking the sum of squares for module expression and dividing by the total sum of squares for each model, which also
corresponded to the multiple R 2 for each linear model. This analysis was performed for each module that was signiﬁcantly correlated
to working, short-term, and long-term memory measures. To determine the variance explained in AD-BXD individuals when amount
of amyloid was added into the model, we ﬁrst used a Type 3
ANOVA to test for signiﬁcant interactions between module expression and amyloid amount. After identifying only one signiﬁcant
module*amyloid interaction (module 4*amyloid for Y-maze %
SA), we continued with an additive Type 2 ANOVA model. For
this model, the same protocol was used as before in which variance
explained was calculated using individual sum of squares for each
independent variable divided by the total sum of squares (including residual sum of squares). Likelihood-ratio (LRT) tests were performed to determine if the addition of cortical Aβ1-42 into the
linear model signiﬁcantly improved the ﬁt. In this calculation,
model 1: cognitive outcome ∼ module expression was tested
against model 2: cognitive outcome ∼ module expression + cortical
www.learnmem.org
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Gene coexpression modules formed by using SpeakEasy clustering
on bulk RNA-seq from human dorsolateral prefrontal cortex
(DL-PFC) tissue were obtained from a previously published
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Religious Orders Study and Memory and Aging Project (ROSMAP)
data set (Mostafavi et al. 2018), as well as coexpression modules
from multiple human brain regions from the Accelerating
Medicine Partnership- Alzheimer’s Disease (AMP-AD) consortium
(Wan et al. 2020). In the Mostafavi study, there were 47 modules
formed with at least 20 gene members, and modules were related
to human cognitive outcomes using a correlation approach similar
to what was performed in this current study. In the AMP-AD study,
there were 30 primary modules generated across seven brain regions and three studies compiled from a meta-analysis of human
aged and AD brains. Human genes from these modules were converted to orthologous mouse genes using the biomaRt() package
in R. Hypergeometric tests were used between each human and
mouse module to examine the degree of conservation between
the two species. The background gene list used was the total number of unique genes that could be found in any human or mouse
module. The Benjamini-Hochberg correction for multiple comparisons was performed to obtain adjusted P-value using the p.adjust()
function in R. All human and mouse modules that passed the preliminary ﬁltering step (mouse modules >29 genes, Mostafavi human modules >20 genes, all AMP-AD modules) were examined
for this analysis.
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Statistical analysis and software
R software version 3.6.3 was used for data analysis. Code for
SpeakEasy clustering was obtained from an online repository
(https://www.cs.rpi.edu/~szymansk/SpeakEasy/index.html)
(Gaiteri et al. 2015), and run in Matlab version 2018a. Statistical
tests included ANOVA, hypergeometric tests for overlap,
Spearman correlations, and Benjamini Hochberg corrections for
multiple testing. All scripts used for these analyses have been posted for open access to GitHub (Heuer_2020) and data ﬁles on
Synapse.org (10.7303/syn17016211). Code for Bayesian modeling
was obtained from an online repository at Synapse.org (10.7303/
syn2910187) (Tasaki et al. 2015).
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